并非所有温度控制都等同:高质量温度控制与院外心脏骤停后结局改善相关
该回顾性单中心研究纳入2014年1月1日至2024年7月19日连续收治的421例接受温度控制的院外心脏骤停患者,基于入院至温度控制装置启动时间及入院6小时内使用辅助药物治疗寒战性产热,构建0–6分温度控制质量评分,按非线性关系二分为低质量(<3分)和高质量(>3分)。194例(46.1%)接受高质量温度控制。高质量组达到目标温度的时间更快(中位5.4小时 vs 8.8小时,标准化均数差=0.79)。逆概率治疗加权前后,高质量温度控制均与出院生存率(调整OR 2.75,95%CI 1.53–5.04)和良好神经功能结局(调整OR 2.05,95%CI 1.10–3.91)相关。作者认为温度控制参数可能影响其神经保护获益,需前瞻性多中心研究评估温度控制质量对患者结局的影响。
要点
- 高质量温度控制定义为质量评分>3分(基于入院至装置启动时间和6小时内辅助药物控制寒战),194/421例(46.1%)达到。
- 高质量温度控制组达到目标温度更快:中位5.4小时 vs 低质量组8.8小时(标准化均数差=0.79)。
- 逆概率治疗加权后,高质量温度控制与出院生存率相关(调整OR 2.75,95%CI 1.53–5.04)。
- 逆概率治疗加权后,高质量温度控制与良好神经功能结局(CPC 1–2)相关(调整OR 2.05,95%CI 1.10–3.91)。
- 作者认为温度控制参数可能重要并影响神经保护获益,需前瞻性多中心研究评估温度控制质量对结局的影响。
适用人群与场景
- 2014年1月1日至2024年7月19日单学术中心连续收治的接受温度控制的院外心脏骤停患者,共421例。
诊断标准与关键阈值
- 温度控制质量评分范围0–6分,基于入院至温度控制装置启动时间及入院6小时内使用辅助药物治疗寒战性产热。
- 按非线性关系二分为低质量(评分<3分)和高质量(评分>3分)。
- 良好神经功能结局定义为大脑功能分类(CPC)评分1–2分。
研究设计与关键结果
- 回顾性单学术中心研究,纳入421例接受温度控制的院外心脏骤停患者,194例(46.1%)接受高质量温度控制。
- 除心脏骤停至达到目标温度时间外,低质量组与高质量组人口学因素、骤停相关细节及复苏后管理相似,总体效应量小。
- 高质量组达到目标温度更快:中位5.4小时(四分位距4.1–8.6) vs 低质量组8.8小时(四分位距7.3–11.0),标准化均数差=0.79。
- 逆概率治疗加权前,高质量温度控制与出院生存率相关(调整OR 2.75,95%CI 1.53–5.04),与良好神经功能结局相关(调整OR 2.05,95%CI 1.10–3.91)。
- 逆概率治疗加权后,高质量温度控制与出院生存率相关(调整OR 2.13,95%CI 1.37–3.34),与良好神经功能结局相关(调整OR 1.94,95%CI 1.16–3.30)。
证据类型、等级与局限
- 证据类型:回顾性单学术中心研究。
- 局限:原文未报告局限性;原文结论指出需前瞻性多中心研究评估温度控制质量对患者结局的影响。
对床旁实践的改变
- 作者认为温度控制参数可能重要,并可能影响温度控制的神经保护获益。
- 作者建议需前瞻性多中心研究评估温度控制质量对患者结局的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVES: Temperature control for survivors of cardiac arrest is a complex bundled intervention with poorly defined optimal parameters. We defined high-quality temperature control initiation and evaluated the association between quality and clinical outcomes.
METHODS: In this retrospective single academic center study between January 1, 2014, and July 19, 2024, consecutive out-of-hospital cardiac arrest patients treated with temperature control were identified. Patients were assigned a temperature control quality score (range 0 to 6) based on the time from hospital arrival to temperature control device initiation and the use of adjunctive pharmacologic treatment for shivering thermogenesis within 6 hours from hospital arrival. Based on the nonlinear relationship between temperature control quality and outcomes, quality was binarized into low quality (less than 3) and high quality (more than 3). The primary outcome was survival to hospital discharge and the secondary outcome was favorable neurologic outcomes, defined as a Cerebral Performance Category score of 1 to 2. We assessed the association between primary and secondary outcomes and temperature control quality using logistic regression. A sensitivity analysis using inverse probability treatment weighting, created using a propensity score, was performed to minimize measurable confounding. Standardized mean difference was used to quantify the difference between groups.
RESULTS: Of the 421 patients treated with temperature control, 194 (46.1%) received high-quality temperature control. Demographic factors, arrest-related details, and postresuscitation management were similar between the low-quality and high-quality groups with an overall small effect size, except for the time from cardiac arrest to achievement of target temperature, which occurred faster in patients with high-quality temperature control (median [interquartile range] 5.4 [4.1, 8.6] versus 8.8 [7.3, 11.0] hours; standardized mean difference=0.79). High-quality temperature control was associated with increased survival to hospital discharge and favorable neurologic outcomes before and after inverse probability treatment weighting (adjusted odds ratio [95% confidence interval] 2.75 [1.53 to 5.04] and 2.05 [1.10 to 3.91] versus 2.13 [1.37 to 3.34] and 1.94 [1.16 to 3.30], respectively).
CONCLUSION: In our single-center study of out-of-hospital cardiac arrest patients, high-quality temperature control was associated with improved survival and good neurologic outcomes. Temperature control parameters are likely important and may influence the neuroprotective benefit of temperature control. Prospective multicenter studies are warranted to evaluate the effect of temperature control quality on patient outcomes.
参考来源
- Beekman R, Nguyen C, Deng Y, et al. Not All Temperature Control Is Equal: High-Quality Temperature Control Is Associated With Improved Outcomes Following Out-of-Hospital Cardiac Arrest. Ann Emerg Med. 2025. PMID: 40817896. doi:10.1016/j.annemergmed.2025.06.622
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。